Mariacristina Di Gangi

Mrs. Mariacristina Di Gangi

Pharmacy, University of Pisa, Pisa, Tuscany, Italy

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
MCMansi Suryakant Chilwant
Mansi Suryakant Chilwant
Valentina PaganiniValentina Paganini
Valentina Paganini
Mariacristina Di GangiMariacristina Di Gangi
Mariacristina Di Gangi
SBSofía Gisella Brignone
Sofía Gisella Brignone
Patrizia ChetoniPatrizia Chetoni
Patrizia Chetoni
Silvia TampucciSilvia Tampucci
Silvia Tampucci
Marine biomass represents a valuable yet underexploited resource for the development of high-value biomaterials. Recent advances have highlighted the significant potential of marine-derived polysaccharides, proteins, and peptides in biomedical applications, most notably in drug delivery and wound healing. This review provides a comprehensive synthesis of current research on the extraction, processing and pharmaceutical valorization of these biopolymers, with a focus on their structural and functional properties that allow these materials to be engineered into nanocarriers, hydrogels, scaffolds, and smart composites. Key fabrication strategies such as ionic gelation, desolvation, and 3D bioprinting are critically examined for their role in drug encapsulation, release modulation, and scaffold design for regenerative therapies. The review also covers preclinical validation, scale-up challenges, and relevant regulatory frameworks, offering a practical roadmap from sustainable sourcing to clinical application. Special attention is given to emerging technologies, including stimuli-responsive biomaterials and biosensor-integrated wound dressings, as well as to the ethical and environmental implications of marine biopolymer sourcing. By integrating materials science, pharmaceutical technology and regulatory insight, this review aims to provide a multidisciplinary perspective for researchers and industrial stakeholders seeking sustainable and multifunctional pharmaceutical platforms for precision medicine and regenerative therapeutics.

24 September 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Silvia TampucciSilvia Tampucci
Silvia Tampucci
Giorgio TofaniGiorgio Tofani
Giorgio Tofani
Patrizia ChetoniPatrizia Chetoni
Patrizia Chetoni
Mariacristina Di GangiMariacristina Di Gangi
Mariacristina Di Gangi
AMAndrea Mezzetta
Andrea Mezzetta
Daniela MontiDaniela Monti
Daniela Monti
In recent years, the demand for high-quality solar products that combine high efficacy with environmentally friendly characteristics has increased. Among the coral-safe sunscreens, ethylhexyl triazone (Uvinul® T150) is an effective organic UVB filter, photostable and practically insoluble in water, therefore difficult to be formulated in water-based products. Oil-free sunscreens are considered ideal for most skin types, as they are not comedogenic and do not leave the skin feeling greasy. Recent studies reported that pollen grains might represent innovative drug delivery systems for their ability to encapsulate and release active ingredients in a controlled manner. Before being used, the pollen grains must be treated to remove cellular material and biomolecules, which could cause allergic reactions in predisposed subjects; the obtained hollow structures possess uniform diameter and a rigid wall with openings that allow them to be filled with bioactive substances. In the present work, pollen from Lycopodium clavatum has been investigated both as a delivery system for ethylhexyl triazone and as an active ingredient by evaluating its photoprotective capacity. The goal is to obtain environmentally friendly solar aqueous formulations that take advantage of both sunscreen and sporopollenin microcapsules’ UV protection with a relatively low cost, as these pollen grains are widely available.

1 October 2025 in Gels
Verified
Journal Article
Open access
PDF file
Valentina PaganiniValentina Paganini
Valentina Paganini
Silvia TampucciSilvia Tampucci
Silvia Tampucci
SBSofía Gisella Brignone
Sofía Gisella Brignone
Mariacristina Di GangiMariacristina Di Gangi
Mariacristina Di Gangi
Daniela MontiDaniela Monti
Daniela Monti
Patrizia ChetoniPatrizia Chetoni
Patrizia Chetoni
Dry eye disease (DED) is a multifactorial condition characterized by insufficient tear film stability and ocular discomfort. Conventional artificial tears offer limited efficacy due to short precorneal residence time. This study aimed to develop and optimize ion-sensitive in situ gelling formulations based on low-acyl gellan gum (GG) and arabinogalactan (AG) to enhance retention and therapeutic efficacy in DED. Various buffer systems were screened to identify optimal gelation conditions upon interaction with artificial tear fluid (ATF). Formulations were characterized by pH, osmolality, wettability, thermal behavior, viscosity, and viscoelastic properties. A Design of Experiments (DoE) approach was employed to understand the influence of GG and AG concentrations on rheological behavior. The selected formulation, GG(0.1%)/AG(0.2%), demonstrated a significant viscosity increase upon ATF dilution, suitable viscoelastic properties, enhanced mucoadhesion compared to hyaluronic acid, improved ferning patterns, no cytotoxic effects, and stability over time. In vivo studies in rabbits confirmed prolonged precorneal retention of the fluorescently labeled formulation. These results suggest that the GG/AG-based hydrogel is a promising strategy for improving the performance of artificial tears in DED treatment.

10 June 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Silvia TampucciSilvia Tampucci
Silvia Tampucci
Daniela MontiDaniela Monti
Daniela Monti
Susi BurgalassiSusi Burgalassi
Susi Burgalassi
Eleonora TerreniEleonora Terreni
Eleonora Terreni
Valentina PaganiniValentina Paganini
Valentina Paganini
Patrizia ChetoniPatrizia Chetoni
Patrizia Chetoni
The treatment of several ocular inflammatory conditions affecting different areas of the ocular globe involves the administration of topical ophthalmic formulations containing corticosteroids. This research was aimed at evaluating the solubilising efficacy of 5.0% w/w of different binary mixtures of commercial amphiphilic polymeric surfactants with the purpose of obtaining nanomicellar solutions containing a high amount of loteprednol etabonate (LE). The selected LE-TPGS/HS nanomicelles, containing 0.253 mg/mL of the drug, had a small size (=13.57 nm) and uniform distribution (Polydispersity Index = 0.271), appeared completely transparent and perfectly filterable through 0.2 μm membrane filter, and remained stable up to 30 days at 4 °C. The critical micellar concentration (CMCTPGS/HS) was 0.0983 mM and the negative value of the interaction parameter between the polymeric-surfactant-building unit (βTPGS/HS = −0.1322) confirmed the ability of the polymeric surfactants to interact, favouring the dissolution of LE into nanomicelles. The disappearance of the endothermic peak of LE in the DSC analysis confirmed the interactions of LE with the polymeric surfactants. LE-TPGS/HS produced in vitro LE which sustained diffusion for 44 h (more than 40% of encapsulated LE). Furthermore, the lack of a significant cytotoxic effect on a sensitive corneal epithelial cell line makes it a candidate for further biological studies.

21 March 2026 in Scientia Pharmaceutica
Verified
Journal Article
Open access
PDF file
Valentina PaganiniValentina Paganini
Valentina Paganini
Mariacristina Di GangiMariacristina Di Gangi
Mariacristina Di Gangi
Patrizia ChetoniPatrizia Chetoni
Patrizia Chetoni
Silvia TampucciSilvia Tampucci
Silvia Tampucci
Daniela MontiDaniela Monti
Daniela Monti
Susi BurgalassiSusi Burgalassi
Susi Burgalassi
Daily exposure to blue light emitted by digital devices has raised concerns about oxidative stress-mediated damage to the ocular surface. Despite growing interest, validated in vitro models to study blue light-induced oxidative stress in corneal epithelial cells remain limited. A reproducible in vitro method was developed using rabbit corneal epithelial (RCE) cells exposed to blue LED light (405 nm). Irradiation parameters were optimized to induce oxidative stress without causing overt cytotoxicity. Cellular viability, intracellular ROS production, and mitochondrial oxidative stress were assessed. The model was validated using reference antioxidants (ascorbic acid and oleuropein), oleuropein formulated in a drug-in-cyclodextrin-in-liposome system (OLE-DCL), and two commercial ophthalmic formulations applied before or after irradiation. Blue light irradiation at 4.57 W/m2 for 30 min significantly increased intracellular and mitochondrial ROS levels while preserving cell viability, indicating sublethal photo-oxidative stress. Ascorbic acid effectively suppressed ROS generation, whereas free oleuropein showed reduced efficacy, likely due to photosensitivity. OLE-DCL significantly enhanced antioxidant activity under irradiation. The model also discriminated between protective and restorative treatment strategies. This study establishes a validated in vitro blue light-induced oxidative stress model for corneal epithelial cells, suitable for screening antioxidant compounds, formulations, and application strategies relevant to ocular surface protection.

21 September 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Valentina PaganiniValentina Paganini
Valentina Paganini
Silvia TampucciSilvia Tampucci
Silvia Tampucci
SBSofía Gisella Brignone
Sofía Gisella Brignone
Mariacristina Di GangiMariacristina Di Gangi
Mariacristina Di Gangi
Daniela MontiDaniela Monti
Daniela Monti
Patrizia ChetoniPatrizia Chetoni
Patrizia Chetoni
Dry Eye Disease (DED) is a multifactorial condition characterized by insufficient tear film stability and ocular discomfort. Conventional artificial tears offer limited efficacy due to short precorneal residence time. This study aimed to develop and optimize ion-sensitive in situ gelling formulations based on low-acyl Gellan Gum (GG) and Arabinogalactan (AG) to enhance retention and therapeutic efficacy in DED. Various buffer systems were screened to identify optimal gelation conditions upon interaction with artificial tear fluid (ATF). Formulations were characterized for pH, osmolality, wettability, thermal behavior, viscosity, and viscoelastic properties. A Design of Experiments (DoE) approach was employed to understand the influence of GG and AG concentrations on rheological behavior. The selected formulation, GG(0.1%)/AG(0.2%), demonstrated a significant viscosity increase upon ATF dilution, suitable viscoelastic properties, enhanced mucoadhesion compared to hyaluronic acid, improved ferning patterns, no cytotoxic effects, and stability over time. In vivo studies in rabbits confirmed prolonged precorneal retention of the fluorescently labeled formulation. These results suggest that the GG/AG-based hydrogel is a promising strategy for improving the performance of artificial tears in DED treatment.